| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
258,990,000 |
| Market
Cap: |
19.11(B) |
| Last
Volume: |
2,501,317 |
Avg
Vol: |
1,900,163 |
| 52
Week Range: |
$65.11 - $82.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 317 |
| Guru Rank Value : 4 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
26,945 |
67,902 |
123,113 |
368,767 |
| Total Sell Value |
$2,043,551 |
$5,004,391 |
$8,902,469 |
$27,563,219 |
| Total People Sold |
3 |
4 |
6 |
10 |
| Total Sell Transactions |
3 |
6 |
8 |
16 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Levy Lawrence M |
Director |
• • – |
2015-11-09 |
4 |
OE |
$17.84 |
$3,568 |
D/D |
200 |
4,114 |
|
- |
|
| Stein Jay A |
Chief Technical Officer |
• • – |
2015-11-09 |
4 |
D |
$39.64 |
$21,207 |
D/D |
(535) |
202,070 |
|
- |
|
| Oberton Karleen Marie |
Corp. VP and Controller |
• • – |
2015-11-09 |
4 |
D |
$39.64 |
$25,925 |
D/D |
(654) |
6,062 |
|
- |
|
| Oberton Karleen Marie |
Corp. VP and Controller |
• • – |
2015-11-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,012 |
6,716 |
|
- |
|
| Egstrand Claus |
SVP and GM, International |
• • – |
2015-11-06 |
4 |
D |
$40.26 |
$71,300 |
D/D |
(1,771) |
3,150 |
|
- |
|
| Egstrand Claus |
SVP and GM, International |
• • – |
2015-11-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,934 |
4,921 |
|
- |
|
| Valenti Peter J. Iii |
Division Pres., Breast Health |
• • – |
2015-11-06 |
4 |
D |
$40.26 |
$26,169 |
D/D |
(650) |
1,257 |
|
- |
|
| Valenti Peter J. Iii |
Division Pres., Breast Health |
• • – |
2015-11-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,907 |
1,907 |
|
- |
|
| Oberton Karleen Marie |
Corp. VP and Controller |
• • – |
2015-11-06 |
4 |
D |
$40.26 |
$24,357 |
D/D |
(605) |
4,704 |
|
- |
|
| Oberton Karleen Marie |
Corp. VP and Controller |
• • – |
2015-11-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,859 |
5,309 |
|
- |
|
| Mcmahon Robert W. |
Chief Financial Officer |
• • – |
2015-11-06 |
4 |
D |
$40.26 |
$46,822 |
D/D |
(1,163) |
7,379 |
|
- |
|
| Mcmahon Robert W. |
Chief Financial Officer |
• • – |
2015-11-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,576 |
8,542 |
|
- |
|
| Compton Eric B. |
COO |
• • – |
2015-11-06 |
4 |
D |
$40.26 |
$47,587 |
D/D |
(1,182) |
6,097 |
|
- |
|
| Compton Eric B. |
COO |
• • – |
2015-11-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,636 |
7,279 |
|
- |
|
| Stein Jay A |
Chief Technical Officer |
• • – |
2015-11-06 |
4 |
D |
$40.26 |
$19,244 |
D/D |
(478) |
202,605 |
|
- |
|
| Stein Jay A |
Chief Technical Officer |
• • – |
2015-11-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,013 |
203,083 |
|
- |
|
| Macmillan Stephen P |
President and CEO |
• • – |
2015-11-06 |
4 |
D |
$40.26 |
$336,574 |
D/D |
(8,360) |
350,354 |
|
- |
|
| Macmillan Stephen P |
President and CEO |
• • – |
2015-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,347 |
358,714 |
|
- |
|
| West Thomas A. |
Div President & GM, Diagnostic |
• • – |
2015-10-03 |
4 |
D |
$39.42 |
$60,194 |
D/D |
(1,527) |
3,036 |
|
- |
|
| West Thomas A. |
Div President & GM, Diagnostic |
• • – |
2015-10-03 |
4 |
OE |
$39.42 |
$160,163 |
D/D |
4,063 |
4,563 |
|
- |
|
| Levy Lawrence M |
Director |
• • – |
2015-09-21 |
4 |
S |
$42.02 |
$210,113 |
D/D |
(5,000) |
3,914 |
|
- |
|
| Levy Lawrence M |
Director |
• • – |
2015-09-21 |
4 |
OE |
$17.84 |
$89,200 |
D/D |
5,000 |
8,914 |
|
- |
|
| Stein Jay A |
Chief Technical Officer |
• • – |
2015-09-11 |
4 |
OE |
$14.50 |
$580,000 |
D/D |
40,000 |
202,070 |
|
- |
|
| Wilson Wayne |
Director |
• • – |
2015-09-08 |
4 |
S |
$39.00 |
$3,900,000 |
D/D |
(100,000) |
39,215 |
|
- |
|
| Wilson Wayne |
Director |
• • – |
2015-09-08 |
4 |
OE |
$32.82 |
$3,281,500 |
D/D |
100,000 |
139,215 |
|
- |
|
824 Records found
|
|
Page 28 of 33 |
|
|
1.20 (1.65%) 
